Clinical Trials

Explore how we turn our research into reality.

About clinical trials

A critical component of developing medicines is clinical research. This involves conducting clinical trials in humans to evaluate the safety and efficacy of investigational medications. Sometimes these studies include healthy volunteers but most of the studies are conducted in patients with the diseases we are studying.

Local authorities, such as the European Medicines Agency (EMA), the Pharmaceuticals and Medical Devices Agency (PMDA) in Japan, the U.S. Food and Drug Administration (FDA), as well as those in many other countries, use the data gathered in these trials to determine whether or not to approve the medication for use in their countries. To ensure these studies are conducted to the highest standards of protection for individuals who participate in the studies, AbbVie strictly follows important rules governing clinical research. These include the World Medical Association’s (WMA) Declaration of Helsinki, the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) and all applicable local rules and regulatory requirements.

Related content

Learn more about AbbVie clinical trials 

The foundation of our uncompromising integrity is our Code of Business Conduct.

We believe in the design of inclusive research programs that offer equitable access and enhanced trial experiences for both patient and physician.

We are committed to being both intentional and representative when it comes to the inclusion of diverse populations of investigator staff and patients in the disease areas we are studying.

Committed to Good Clinical Practice

Throughout the clinical trials process, patients remain our highest priority. Good Clinical Practice (GCP) is a global ethical and scientific quality standard for designing, conducting, recording and reporting clinical trials. Compliance with this standard provides public assurance that the rights, safety and well-being of trial subjects are protected, consistent with global ethical standards and regulatory requirements. Compliance also assures the credibility of the clinical data. AbbVie is committed to ensuring Good Clinical Practice is strictly adhered to within all AbbVie-sponsored clinical trials.

Additional Information

Join our clinical trial site network

AbbVie partners with leading scientific and medical professionals around the world to conduct clinical trials. We value the significant contributions that our scientific and medical professional partners make to our scientific innovation. AbbVie is committed to establishing collaborative partnerships to continuously grow our clinical trial site network.

To become a clinical trial investigator / investigative site on an AbbVie trial, submit your interest here:

Investigator-Initiated Studies (IIS) Program

The Investigator-Initiated Studies (IIS) Program provides an opportunity for academic and community-based physicians and researchers worldwide interested in conducting their own research to apply for research support. To learn about investigator-initiated studies, please visit this page.